| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.009 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |